AI-generated summary
In this randomized controlled trial of 55 patients with diabetic polyneuropathy, the authors compared low-power laser therapy and low-frequency ultrasound with a control group, all alongside standard care. The laser group showed the largest improvements in quality-of-life problem scores, which was significant against controls, though between-group differences in neuropathy screening scores were not significant. The authors describe the findings as preliminary and the clinical utility as uncertain.
- Participants
- 55
- Who or what was studied
- Patients with diabetic polyneuropathy
- Wavelengths
- 808, 905 nm
- Limits stated in the abstract
- The authors state that between-group differences were limited, and that larger, multicenter trials with longer follow-up are needed to confirm the preliminary findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm, 905 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Randomized controlled trial, Laser, Neuropathy, Duty cycle, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.